↓ Skip to main content

MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015 - Volume 23, Number 7—July 2017 - Emerging Infectious Diseases journal - CDC

Overview of attention for article published in Emerging Infectious Diseases, July 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
20 news outlets
blogs
1 blog
policy
1 policy source
twitter
38 X users
patent
1 patent
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
215 Dimensions

Readers on

mendeley
217 Mendeley
Title
MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015 - Volume 23, Number 7—July 2017 - Emerging Infectious Diseases journal - CDC
Published in
Emerging Infectious Diseases, July 2017
DOI 10.3201/eid2307.170310
Pubmed ID
Authors

Pyoeng Gyun Choe, R.A.P.M. Perera, Wan Beom Park, Kyoung-Ho Song, Ji Hwan Bang, Eu Suk Kim, Hong Bin Kim, Long Wei Ronald Ko, Sang Won Park, Nam-Joong Kim, Eric H.Y. Lau, Leo L.M. Poon, Malik Peiris, Myoung-don Oh

Abstract

We investigated the kinetics of the Middle East respiratory syndrome coronavirus (MERS-CoV) neutralizing and spike protein antibody titers over the course of 1 year in 11 patients who were confirmed by reverse transcription PCR to have been infected during the outbreak in South Korea in 2015. Robust antibody responses were detected in all survivors who had severe disease; responses remained detectable, albeit with some waning, for <1 year. The duration of viral RNA detection (but not viral load) in sputum significantly correlated with the antibody response magnitude. The MERS S1 ELISA antibody titers correlated well with the neutralizing antibody response. Antibody titers in 4 of 6 patients who had mild illness were undetectable even though most had evidence of pneumonia. This finding implies that MERS-CoV seroepidemiologic studies markedly underestimate the extent of mild and asymptomatic infection. Obtaining convalescent-phase plasma with high antibody titers to treat MERS will be challenging.

X Demographics

X Demographics

The data shown below were collected from the profiles of 38 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 217 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 217 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 46 21%
Student > Master 26 12%
Student > Ph. D. Student 18 8%
Student > Bachelor 17 8%
Other 12 6%
Other 44 20%
Unknown 54 25%
Readers by discipline Count As %
Medicine and Dentistry 45 21%
Immunology and Microbiology 37 17%
Biochemistry, Genetics and Molecular Biology 21 10%
Agricultural and Biological Sciences 13 6%
Veterinary Science and Veterinary Medicine 6 3%
Other 28 13%
Unknown 67 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 195. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 February 2022.
All research outputs
#206,030
of 25,703,943 outputs
Outputs from Emerging Infectious Diseases
#349
of 9,781 outputs
Outputs of similar age
#4,287
of 324,917 outputs
Outputs of similar age from Emerging Infectious Diseases
#6
of 121 outputs
Altmetric has tracked 25,703,943 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,781 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 44.7. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 324,917 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 121 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.